Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Endocrinology

The Detective Work: Finding the Cause of Low Bone Density

At a Glance

Low bone density before menopause often has an underlying cause, such as a nutrient-absorption problem, hormone disorder, medication effect, or inherited condition. A targeted blood, urine, and imaging workup can help identify it and guide treatment that may slow further bone loss.

If you are premenopausal and have been diagnosed with osteoporosis or “below expected bone mass,” your doctor’s most important job is to become a detective. In many cases, low bone density in younger women is not a standalone problem but a symptom of an underlying contributing cause elsewhere in the body [1][2].

Identifying and treating these secondary causes can often stop bone loss or even help you regain bone density naturally without the need for osteoporosis medications [3][4].

The Search for the Contributing Cause

Most premenopausal bone loss is caused by conditions that interfere with how your body builds bone or how it absorbs the minerals needed to keep bones strong. Your diagnostic workup will likely focus on several major categories:

1. Silent Digestive Issues

You can have a digestive condition that “steals” nutrients from your bones even if you don’t have a stomachache. Celiac disease is a common culprit; it causes the body to attack the lining of the small intestine, preventing the absorption of calcium and vitamin D [5][3]. Other silent issues include inflammatory bowel disease (IBD) or the long-term effects of weight-loss surgery [2].

2. Hormonal (Endocrine) Disruptions

Bones rely on a delicate balance of hormones. Common contributing causes include:

  • Amenorrhea (Missed Periods): Estrogen is vital for bone health. If your periods have stopped due to excessive exercise, low body weight, or stress, your bones lose their primary protector [2][6].
  • Hyperthyroidism: An overactive thyroid speeds up bone breakdown [7].
  • Hyperparathyroidism: If your parathyroid glands produce too much hormone, they “leach” calcium out of your bones and into your blood [8][9].

3. Medication Side Effects

Some medications can affect bone health when used long-term. The most common are glucocorticoids (steroids like prednisone) used for asthma or autoimmune issues [10]. Other medications that can affect bones include certain anti-seizure drugs, proton-pump inhibitors (for reflux), and some antidepressants [10][11]. Note: Never stop or change your prescribed medications on your own, as risks depend on the drug, dose, and your underlying illness.

The Standard Diagnostic Workup

A thorough evaluation involves more than just a quick scan. Your medical team should use a combination of clinician-directed testing and detailed blood work to map out your bone health.

Imaging: Looking Beyond the Surface

  • DXA Scan with Z-scores: As discussed on previous pages, your DXA must be interpreted using Z-scores (comparing you to your peers) rather than T-scores [1].
  • Vertebral Fracture Assessment (VFA): This is a low-dose X-ray often done at the same time as a DXA. It allows the doctor to see the shape of your vertebrae to catch silent fractures. Its use is selective and depends on symptoms, height loss, and fracture risk rather than being routine for everyone [12][13].
  • Spine MRI or X-ray: If you have focal back pain or height loss, a dedicated X-ray or MRI provides a much clearer picture of your spinal health than a DXA alone [14][15].

The Lab Panel: Blood and Urine Tests

To find the underlying cause, your doctor will typically order a “bone battery” of tests:

  • Calcium and Vitamin D: To check if your bones have the raw materials they need [16].
  • PTH (Parathyroid Hormone): To see if your body is actively pulling calcium out of your bones [9].
  • TSH (Thyroid Stimulating Hormone): To rule out thyroid-driven bone loss [17].
  • Celiac Serology: A blood test (usually total IgA and an IgA/IgG assay) to evaluate for celiac disease [4][5]. Do not start a gluten-free diet before testing, as doing so can make the blood tests falsely negative.
  • 24-Hour Urine Calcium: This test measures how much calcium your kidneys are excreting, which helps determine dietary intake, absorption issues, and kidney function [4][18].
  • Metabolic Panel and Inflammation Markers: Blood tests like ESR or CRP can check for inflammation, alongside a metabolic panel to check kidney and liver function [16][19].

When the Cause is Genetic

If your labs are normal and you have no history of bone-damaging medications or illnesses, your doctor may look at your family history. In some younger women, particularly those with multiple low-trauma fractures or characteristic features, specialized genetic testing can evaluate for rare inherited variants (such as Osteogenesis Imperfecta) [20][21]. This is a targeted next step and is not standard for every unexplained low Z-score [20].

By identifying the “why” behind your bone density, you and your doctor can move away from general worry and toward a specific, effective treatment plan.

Common questions in this guide

What can cause osteoporosis before menopause?
Low bone density before menopause often has a secondary cause rather than being an isolated problem. Common possibilities include celiac disease or other intestinal conditions, missed periods related to low body weight or intense exercise, thyroid or parathyroid disorders, long-term medication use, and rarely an inherited bone disorder.
What tests are usually included in a workup for premenopausal osteoporosis?
Evaluation may include a DXA bone-density scan interpreted with a Z-score and blood tests for calcium, vitamin D, parathyroid hormone, thyroid-stimulating hormone, kidney and liver function, and inflammation. Doctors may also order celiac blood tests and a 24-hour urine calcium test, with spine imaging when symptoms or height loss suggest a vertebral problem.
Should I stop eating gluten before being tested for celiac disease?
No. Starting a gluten-free diet before celiac blood tests can make the results falsely negative, so talk with your clinician before changing your diet.
When is a vertebral fracture assessment or spine scan needed?
A vertebral fracture assessment may be considered with a DXA when symptoms, height loss, or fracture risk raises concern for a silent spinal fracture; it is not routine for everyone. Focal back pain or height loss may also lead to a dedicated spine X-ray or MRI.
Can my medications be causing low bone density?
Yes, long-term glucocorticoids such as prednisone are a common medication-related cause, and some anti-seizure medicines, proton-pump inhibitors, and antidepressants may also affect bone health. Do not stop or change a prescription on your own; ask your clinician to review the drug, dose, duration, and risks of your underlying illness.
When might genetic testing be considered for low bone density before menopause?
Genetic testing may be considered when standard blood tests are normal, there is no clear medication- or illness-related cause, and you have multiple low-trauma fractures or features suggesting an inherited bone disorder. It is a targeted evaluation and is not routine for every person with an unexplained low Z-score.
Does a low Z-score always mean I have osteoporosis?
No. A Z-score compares your bone density with that of people of similar age and sex, but it does not by itself explain why your bone density is low. If you have no fractures or secondary cause, your clinician may focus on monitoring and bone-health measures rather than automatically starting medication.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Could we review my secondary cause lab panel? Specifically, was my 24-hour urine calcium and celiac screen included?
  2. 2.If my Z-score is low but I have no fractures and no secondary causes, does that change how we monitor my bone health?
  3. 3.Should we perform a Vertebral Fracture Assessment (VFA) alongside my DXA to rule out any silent fractures in my spine?
  4. 4.Are any of my current medications, even those I've taken for a long time, potentially affecting my bone density?
  5. 5.At what point would we consider genetic testing to see if there is an inherited reason for my low bone density?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Premenopausal osteoporosis.

    Conradie M, de Villiers T

    Climacteric : the journal of the International Menopause Society 2022; (25(1)):73-80 doi:10.1080/13697137.2021.1926974.

    PMID: 34036859
  2. 2

    How to manage osteoporosis before the age of 50.

    Rozenberg S, Bruyère O, Bergmann P, et al.

    Maturitas 2020; (138()):14-25 doi:10.1016/j.maturitas.2020.05.004.

    PMID: 32631584
  3. 3

    Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.

    Pepe J, Body JJ, Hadji P, et al.

    The Journal of clinical endocrinology and metabolism 2020; (105(8)) doi:10.1210/clinem/dgaa306.

    PMID: 32453819
  4. 4

    High prevalence of laboratory abnormalities indicative of secondary osteoporosis detected by systematic testing.

    Shah N, Galitzer H, Yalamanchi S, Sellmeyer DE

    JBMR plus 2025; (9(7)):ziaf089 doi:10.1093/jbmrpl/ziaf089.

    PMID: 40584155
  5. 5

    Celiac Disease and Its Role in the Development of Metabolic Bone Disease.

    Micic D, Rao VL, Semrad CE

    Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2020; (23(2)):190-199 doi:10.1016/j.jocd.2019.06.005.

    PMID: 31320223
  6. 6

    Serum anti-Müllerian hormone levels are associated with low bone mineral density in premenopausal women.

    Yan Y, Chen W, Wang J, et al.

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2020; (25(8)):693-700 doi:10.1080/1354750X.2020.1833083.

    PMID: 33025829
  7. 7

    Mechanisms and Treatment Options for Hyperthyroid-Induced Osteoporosis: A Narrative Review.

    Branstetter RM, Islam RK, Toups CA, et al.

    Cureus 2023; (15(11)):e48798 doi:10.7759/cureus.48798.

    PMID: 38098934
  8. 8

    Bone Mineral Density and First Line Imaging with [18F]fluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center.

    Schaffler-Schaden D, Schweighofer-Zwink G, Hehenwarter L, et al.

    Diagnostics (Basel, Switzerland) 2024; (14(22)) doi:10.3390/diagnostics14222466.

    PMID: 39594132
  9. 9

    Secondary hyperparathyroidism: Predictors and relationship with vitamin D status, bone turnover markers and bone mineral density.

    Fitzpatrick D, Laird E, Ward M, et al.

    Bone 2024; (184()):117108 doi:10.1016/j.bone.2024.117108.

    PMID: 38642819
  10. 10

    Linking the relationship between drug-induced osteoporosis and the gut microbiota.

    Martiniakova M, Sarocka A, Penzes N, et al.

    Frontiers in endocrinology 2026; (17()):1818207 doi:10.3389/fendo.2026.1818207.

    PMID: 42305264
  11. 11

    Vertebral fractures in a young woman: the impact of hypogonadism, glucocorticoids and chronic disease.

    Herath M, Nguyen HH, Milat F, Ebeling PR

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2026; doi:10.1093/jbmr/zjag088.

    PMID: 42176199
  12. 12

    Bone mineral density measurement combined with vertebral fracture assessment increases diagnosis of osteoporosis in postmenopausal women.

    Cai S, Yu H, Li Y, et al.

    Skeletal radiology 2020; (49(2)):273-280 doi:10.1007/s00256-019-03280-3.

    PMID: 31352490
  13. 13

    Vertebral Fractures Beyond Bone Density in Breast Cancer: A Real-World Study of Endocrine Therapy and FRAX Reclassification.

    Kollár R, Leel-Őssy T, Szigeti E, et al.

    Journal of clinical medicine 2026; (15(13)) doi:10.3390/jcm15134905.

    PMID: 42452367
  14. 14

    Bone health in patients with cancer: a SEOM-SEIOMM consensus review of risk factors, assessment strategies, and management approaches.

    Beato-Zambrano C, Nogues X, Ramírez-Merino N, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; (28(8)):3059-3074 doi:10.1007/s12094-026-04256-1.

    PMID: 41703396
  15. 15

    Secondary thoracolumbar deformity and sagittal imbalance due to osteoporosis in a young man with Cushing's disease: A case report.

    Ramírez-Villaescusa J, Ruiz-Picazo D, Oliveira CL, Morillas-Ariño C

    International journal of surgery case reports 2020; (76()):134-138 doi:10.1016/j.ijscr.2020.09.182.

    PMID: 33032043
  16. 16

    Secondary osteoporosis.

    Sheu A, Diamond T

    Australian prescriber 2016; (39(3)):85-7 doi:10.18773/austprescr.2016.038.

    PMID: 27346916
  17. 17

    Osteoporosis in premenopausal women.

    Peris P

    Medicina clinica 2025; (164(10)):106940 doi:10.1016/j.medcli.2025.106940.

    PMID: 40267754
  18. 18

    Osteoporosis: Investigations and Monitoring.

    Panchagnula R, Amarnath SS

    Indian journal of orthopaedics 2023; (57(Suppl 1)):70-81 doi:10.1007/s43465-023-01019-w.

    PMID: 38107808
  19. 19

    [Differential diagnoses of osteoporosis].

    Stumpf U, Hesse E, Böcker W, et al.

    Zeitschrift fur Gerontologie und Geriatrie 2019; (52(5)):414-420 doi:10.1007/s00391-019-01571-x.

    PMID: 31297588
  20. 20

    Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.

    Oheim R, Tsourdi E, Seefried L, et al.

    The Journal of clinical endocrinology and metabolism 2022; (107(7)):e3048-e3057 doi:10.1210/clinem/dgac147.

    PMID: 35276006
  21. 21

    Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.

    Costantini A, Mäkitie RE, Hartmann MA, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(9)):1623-1641 doi:10.1002/jbmr.4668.

    PMID: 35949115

This page is for informational purposes only and does not constitute medical advice. Your healthcare team should interpret your DXA results, laboratory tests, and fracture risk and advise you about your care.

Get notified when new evidence is published on premenopausal osteoporosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.